Sat.Aug 05, 2023 - Fri.Aug 11, 2023

article thumbnail

Molecules of the Month – July 2023

Drug Hunter

This month features big announcements from Biogen on their acquisition of Reata and their Nrf2 activator for Friedreich’s ataxia and from BridgeBio on their TTR stabilizer with positive Ph. III data for their ATTR-CM treatment. A pair of KRAS inhibitors from Chugai (macrocycle) and AstraZeneca (brain-penetrant) also makes the list for their notable pharmacology.

Treatment 218
article thumbnail

A novel alpha?amylase inhibitor?based spirooxindole?pyrrolidine?clubbed thiochromene?pyrzaole pharmacophores: Unveiling the [3+2] cycloaddition reaction by molecular electron density theory

Chemical Biology and Drug Design

Designed a novel of spirooxindole-pyrrolidine clubbed thiochromene and pyrazole motifs synthesized by [3+2] cycloaddition (32CA) reactions in one step process and identified as an alpha-amylase inhibitor. Mechanistic study for the 32CA reaction by Molecular Electron Density Theory (MEDT) was explored. Abstract A novel spirooxindole-pyrrolidine clubbed thiochromene and pyrazole motifs were synthesized by [3+2] cycloaddition (32CA) reactions in one step process starting from the ethylene-based thi

Drugs 190
article thumbnail

Novo Nordisk’s Huge Financial Bet On Obesity Drug Wegovy Wins Big

Forbes: Drug Truths

The SELECT trial is a game changer. Yes, Novo Nordisk achieved winning results. But obesity patients with heart disease now have a major new drug to extend their lives – and that’s an even bigger win.

Drugs 171
article thumbnail

HIV cell therapy startup Addimmune heads to Wall Street via blank-check merger

BioPharma Drive: Drug Pricing

The deal will help fund a cell-based treatment that completed Phase 1 testing last year and is designed to provide a “functional cure” for patients with HIV infections.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Antidote Partner Profile: A Q&A with Patients Rising

Antidote

Helping patients find out about clinical trials is one of the chief pillars of the work Antidote does, and one of the ways we do this is through our partners. By building a network of nonprofits and patient advocacy groups, we are able to reach patients where they are and help them find clinical trial opportunities that may be a good fit.

article thumbnail

Bad Sleep Can Harm Your Heart, and Weekend 'Catch-Up' Sleep Won't Help

Drugs.com

FRIDAY, Aug. 11, 2023 -- Poor sleep takes a toll, and catching up on the weekends just won't fix it, researchers report. A small new study showed that heart rate and blood pressure, important measures of cardiovascular health, worsen as the week.

More Trending

article thumbnail

J&J grows cancer drug portfolio with newly approved bispecific

BioPharma Drive: Drug Pricing

The drug, which will be sold under the brand name Talvey, is now cleared by the FDA to treat multiple myeloma, a blood cancer that J&J has identified as a research priority.

FDA 98
article thumbnail

3 Key Takeaways from Psychedelic Science 2023

Conversations in Drug Development Trends

As one of the more recent fields to emerge in the clinical space, psychedelics have gained significant traction as a potential treatment for various neuropsychiatric diseases. With so many exciting developments in the last few years, it’s critical for the psychedelic community to come together to reflect on our progress, share the latest discoveries, and discuss the future of psychedelic research.

Science 98
article thumbnail

The Covenant of Water by Abraham Verghese: A Geneticist’s Review

PLOS: DNA Science

The history of genetics begins, not with Gregor Mendel’s pea experiments, but with people long ago noticing family resemblances and vulnerabilities so distinctive that shared environment alone can’t explain them. In the new literary fiction masterpiece The Covenant of Water , author-physician Abraham Verghese traces an unusual trait through three generations of a Christian family in India, against the historical backdrop of the coalescence of three states into Kerala, on the Malabar

Disease 98
article thumbnail

People With Autism Face Much Higher Risk for Self-Harm, Suicide

Drugs.com

THURSDAY, Aug. 10, 2023 -- People with autism are over three times more likely than their peers without the developmental disorder to experience self-injury, suicidal ideation, suicide attempt, or death by suicide, new research shows. “In.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Emergent to lay off around 400 in pivot away from contract manufacturing

BioPharma Drive: Drug Pricing

The job cuts will affect “all areas of the company” and, combined with other cost-reduction efforts, lead to annualized savings of over $100 million, Emergent said.

98
article thumbnail

What to know about persistent corneal epithelial defects

Antidote

Persistent corneal epithelial defects are more than just an eye injury. The corneal epithelium is an integral part of the eye , tasked with guarding against infection and structural damage. While most injuries to the corneal epithelium are able to heal within a week , these persistent injuries will continue well past the seven-day mark. If they remain unresponsive to standard treatments, the condition is referred to as a persistent corneal epithelial defect.

article thumbnail

A Molecular Portrait of ALS and FTD

Drug Target Review

Published on bit.bio’s website, this article authored by Dr Tony Oosterveen dives into the close relationship between FTD and ALS with a focus on mechanisms underlying the neuropathology of both diseases. On April 30th, 1939, baseball hall of famer Lou Gehrig stepped up to the plate with weary muscles. Over the course of Gehrig’s 15-year career, fans and teammates had dubbed him the “Ironhorse” as a nod to the fact that neither illness, injury, nor fatigue had ever caused him to miss a gam

RNA 98
article thumbnail

How Many Daily Steps to Lengthen Your Life? Fewer Than You Might Think

Drugs.com

WEDNESDAY, Aug. 9, 2023 -- If you’re one of the millions of folks bent on racking up at least 10,000 steps a day, read on. A new study finds that heart health starts to improve with as few as 2,300 steps a day. The research also indicates.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Lilly market value soars on higher sales, obesity drug potential

BioPharma Drive: Drug Pricing

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

article thumbnail

Integrate Sitecore Form into a JSS app (React/Next.js) in Headless Architecture.

Perficient: Drug Development

Everyone is moving toward headless architecture these days and wants to take advantage of the new approach in the CMS industry to improve the CMS experience. However, in a few cases, it does not support a CMS functionality like Sitecore Form. Sitecore does not have any out of the box (OOB) component to implement Sitecore Form. Although Sitecore has provided different approaches and advice on how to integrate Sitecore Form in JSS app.

article thumbnail

NIEHS and NIOSH Explore the Expansion of Recovery Friendly Workplace Programs

NIOSH Science Blog: Drugs

Recovery friendly workplaces (RFWs) have emerged around the United States as an important intervention to both prevent and address substance use disorders (SUD) and the opioid overdose crisis among workers. A RFW program strives to prevent SUD and overdose by creating a safe, hazard-free and healthy workplace by reducing the chance of injury and the subsequent use of opioids, providing support for workers who are struggling, and facilitating opportunities for employment for people in treatment a

article thumbnail

Vacations in the Sun Aren't Good for Your Skin's Microbiome

Drugs.com

WEDNESDAY, Aug. 9, 2023 -- It’s already known that the “healthy glow” of a tan actually represents damage to skin cells. But a new study of people on vacation has found that sunbathing also can disrupt the skin’s microbiome, altering the.

98
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

How the right technology and tools can accelerate progress in rare disease clinical trials

BioPharma Drive: Drug Pricing

The need for more research into rare diseases is clear, but researchers face significant challenges. Fortunately, technology has created opportunities to innovate in clinical trials for rare diseases.

article thumbnail

Boosting Node.js Performance and Efficiency with Redis

Perficient: Drug Development

In today’s web development, being fast and responsive is really important. Users want smooth experiences, and developers work hard to make apps that do just that. This is where Node.js and Redis come in. When used together, they can make your apps work much faster and better. In this article, we’ll look at how to use Redis with Node.js to make applications that are super quick and responsive.

article thumbnail

Stem cell therapy rescues symptoms of Alzheimer’s disease

SCIENMAG: Medicine & Health

In the ongoing search for a cure for Alzheimer’s disease, a burgeoning branch of medicine is bringing new hope. Stem cell therapies are already being used to treat various cancers and disorders of the blood and immune system.

article thumbnail

Surgeons Are Finding Microplastics in Human Hearts

Drugs.com

THURSDAY, Aug. 10, 2023 -- Microplastics appear to be everywhere, including within the tissues of the human heart. A new Chinese report describes doctors finding microplastics in heart tissue both before and after heart surgery. The researchers also.

Doctors 98
article thumbnail

Novo obesity drug protects heart health in large trial

BioPharma Drive: Drug Pricing

Treatment with Wegovy led to a 20% reduction in the relative risk of cardiovascular complications or death, a finding that could further shift how doctors treat obesity.

Trials 98
article thumbnail

Daphnia in Ecotoxicology: Unveiling Aquatic Contaminant Effects

biobide

Daphnia genus species, such as Daphnia magna , commonly known as daphnid or water flea, are plankton-feeding crustaceans that can be found in most bodies of water. These animals have very protuberant external features that make them unique like their single big eye and the duple pairs of branched antennae. The crustacean uses the antennae for locomotion and the thorax and the belly are covered and protected by an uncalcified translucent shell made out of chitin, which is a polysaccharide.

Drugs 94
article thumbnail

Interdisciplinary team studies decomposition effects on soil

SCIENMAG: Medicine & Health

Forensic researchers at the University of Tennessee Knoxville’s famous Anthropological Research Facility, popularly known as the “Body Farm,” have made headlines for decades in their discoveries of what happens to human bodies after death.

article thumbnail

New COVID Variant EG.5 Now Dominant in U.S., CDC Says

Drugs.com

TUESDAY, Aug. 8, 2023 – A variant nicknamed Eris now accounts for the largest proportion of new COVID infections across America. About 17.3% of U.S. COVID cases are believed to have been caused by the variant, formally known as EG.5, in early.

98
article thumbnail

Astellas to expand presence in Massachusetts with new research hub

BioPharma Drive: Drug Pricing

The planned facility in the biotech hotspot of Cambridge will include incubator space for startups and adds to Astellas’ R&D footprint in the Boston area.

article thumbnail

The Use of Zebrafish as New Alternative Model in Eye Disease.

biobide

The observation of the Zebrafish’s (Danio rerio) innate capacity to regenerate retinal cells has resulted in its identification as an ideal New Alternative Model (NAM) for ocular disease research. As a result of the negative impact on the person’s quality of life that visual impairment causes and the high amount of people suffering from this condition, an estimated 295 million people are believed to suffer from moderate to severe visual impairment worldwide, the study of eye diseases is of high

Disease 94
article thumbnail

An unexpected way to upcycle: Plastic waste transforms into soap

SCIENMAG: Medicine & Health

A team led by Virginia Tech researchers has developed a new method for upcycling plastics into high-value chemicals known as surfactants, which are used to create soap, detergent, and more. Credit: Photo by Steven Mackay for Virginia Tech.

article thumbnail

Bella Hadid Opens Up About Lyme Disease Battle

Drugs.com

TUESDAY, Aug. 8, 2023 -- Top model Bella Hadid is talking about being "finally healthy" and feeling well after more than a decade of health issues, including Lyme disease. Hadid shared her struggle on Instagram after what she described as "almost.

Disease 98
article thumbnail

Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line

BioPharma Drive: Drug Pricing

Filed in Maryland district court, the lawsuit claims the biotech unjustly profited from using HeLa cells to develop AAV vectors for its gene therapy products.

article thumbnail

Monolithic vs. Microservice Architecture: Choosing the Right Path for Your Application

Perficient: Drug Development

Introduction In the ever-evolving landscape of software development, choosing the right architectural approach is crucial for building robust and scalable applications. Two popular architectural styles that often come into consideration are Monolithic and Microservice. Both have their merits and trade-offs and understanding their differences is vital for making an informed decision that aligns with your project’s goals.

article thumbnail

Microplastics found embedded in tissues of whales and dolphins

SCIENMAG: Medicine & Health

BEAUFORT, N.C. – Microscopic plastic particles have been found in the fats and lungs of two-thirds of the marine mammals in a graduate student’s study of ocean microplastics. The presence of polymer particles and fibers in these animals suggests that microplastics can travel out of the digestive tract and lodge in the tissues.

93